NeuroSense Therapeutics Ltd. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| JANE STREET GROUP, LLC | 02/14/2025 | 64,636 | $77,563 | 100.00% | 0.36% |
| HRT FINANCIAL LP | 02/14/2025 | 64,390 | $77,000 | 100.00% | 0.36% |
| XTX TOPCO LTD | 02/13/2025 | 41,897 | $50,276 | -8.91% | 0.23% |
| MEITAV INVESTMENT HOUSE LTD | 02/03/2025 | 40,000 | $48,000 | 0.00% | 0.22% |
| STRATOS WEALTH PARTNERS, LTD. | 01/27/2025 | 20,000 | $24,000 | 100.00% | 0.11% |
| COMMONWEALTH EQUITY SERVICES, LLC | 02/10/2025 | 16,250 | $20,000 | 28.71% | 0.09% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 15,870 | $19,044 | 32.66% | 0.09% |
| TWO SIGMA SECURITIES, LLC | 02/14/2025 | 15,017 | $18,020 | 100.00% | 0.08% |
| WARBERG ASSET MANAGEMENT LLC | 02/13/2025 | 10,700 | $12,840 | 100.00% | 0.06% |
| CWM, LLC | 02/04/2025 | 1,000 | $1,000 | 0.00% | 0.01% |
| 02/06/2025 | 175 | $210 | 100.00% | 0.00% | |
| CANTOR FITZGERALD, L. P. | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
NeuroSense Therapeutics Ltd. institutional Ownership - FAQ's
During the previous two years, 13 institutional investors and hedge funds held shares of NeuroSense Therapeutics Ltd.. The most heavily invested institutionals were:
JANE STREET GROUP, LLC: 64,636
HRT FINANCIAL LP: 64,390
XTX Topco Ltd: 41,897
MEITAV INVESTMENT HOUSE LTD: 40,000
Stratos Wealth Partners, LTD.: 20,000
COMMONWEALTH EQUITY SERVICES, LLC: 16,250
3.58% of NeuroSense Therapeutics Ltd. stock is owned by institutional investors.
Institutional investors have bought a total of 324,040 shares in the last 24 months. This purchase volume represents approximately $392,088 in transactions.